US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Prudential Financial, Inc.

23.91

+0.01000.04%

Post-market: 23.910.00000.00%16:10 EST

Volume:16.22K

Turnover:387.54K

Market Cap:841.43M

PE:3.19

High:23.95

Open:23.88

Low:23.81

Close:23.90

52wk High:25.19

52wk Low:22.35

Shares:35.19M

Float Shares:35.19M

Volume Ratio:0.49

T/O Rate:0.05%

Dividend:1.41

Dividend Rate:5.88%

EPS(TTM):7.50

EPS(LYR):10.23

ROE:7.52%

ROA:0.37%

PB:0.01

PE(LYR):2.34

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting

Press Release: Prudential Financial, Inc. to Announce Fourth Quarter 2025 Earnings; Schedules Conference Call

Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening

Benzinga_recent_news

PRS REIT Shareholders Approve Strategic Sale and Liquidation Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PRS"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRS\",,,,,undefined,":{"symbol":"PRS","market":"US","secType":"STK","nameCN":"Prudential Financial, Inc.","latestPrice":23.91,"timestamp":1770411600000,"preClose":23.9,"halted":0,"volume":16219,"hourTrading":{"tag":"盘后","latestPrice":23.91,"preClose":23.91,"latestTime":"16:10 EST","volume":8,"amount":191.28,"timestamp":1770412204532,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0004184100418410696,"floatShares":35191700,"shares":35191700,"eps":7.5,"marketStatus":"Market Closed","change":0.01,"latestTime":"02-06 16:00:00 EST","open":23.88,"high":23.95,"low":23.81,"amount":387542.9176,"amplitude":0.005858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.5,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":23.9,"dividendRate":0.058814,"postHourTrading":{"tag":"盘后","latestPrice":23.91,"preClose":23.91,"latestTime":"16:10 EST","volume":8,"amount":191.28,"timestamp":1770412204532,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4853488634244613},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRS\",,,,,undefined,":{"symbol":"PRS","floatShares":35191700,"roa":"0.37%","roe":"7.52%","lyrEps":10.227272,"volumeRatio":0.4853488634244613,"shares":35191700,"dividePrice":1.406248,"high":23.95,"amplitude":0.005858,"preClose":23.9,"low":23.81,"week52Low":22.3517,"pbRate":"0.01","week52High":25.19,"institutionHeld":0.0085,"latestPrice":23.91,"eps":7.5,"divideRate":0.058814,"volume":16219,"delay":0,"ttmEps":7.5,"open":23.88,"prevYearClose":23.82,"prevWeekClose":24,"prevMonthClose":24,"prevQuarterClose":23.82,"fiveDayClose":24,"twentyDayClose":23.93,"sixtyDayClose":24.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRS\",params:#limit:5,,,undefined,":[{"date":"2026-02-03","symbol":"PRS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770152400000,"name":null,"time":"Post Market","dateTimestamp":1770094800000,"actualEps":null},{"date":"2026-01-30","symbol":"PRS","amount":0.3515625,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-30","defaultRemindTime":1769783400000,"name":"Prudential Financial, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-17","payableDate":"2026-01-30","currency":"USD","dateTimestamp":1769749200000,"payDate":"2026-02-17"},{"date":"2025-10-31","symbol":"PRS","amount":0.3515625,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-31","defaultRemindTime":1761917400000,"name":"Prudential Financial, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-17","payableDate":"2025-10-31","currency":"USD","dateTimestamp":1761883200000,"payDate":"2025-11-17"},{"date":"2025-10-29","symbol":"PRS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761768000000,"name":null,"time":"Post Market","dateTimestamp":1761710400000,"actualEps":null},{"date":"2025-08-01","symbol":"PRS","amount":0.3515625,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-01","defaultRemindTime":1754055000000,"name":"Prudential Financial, Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-08-01","currency":"USD","dateTimestamp":1754020800000,"payDate":"2025-08-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRS\",market:\"US\",,,undefined,":[{"executeDate":"2018-10-31","recordDate":"2018-11-01","paymentDate":"2018-11-15","value":0.359375,"currency":"USD"},{"executeDate":"2019-01-31","recordDate":"2019-02-01","paymentDate":"2019-02-15","value":0.3515625,"currency":"USD"},{"executeDate":"2019-04-30","recordDate":"2019-05-01","paymentDate":"2019-05-15","value":0.3515625,"currency":"USD"},{"executeDate":"2019-07-31","recordDate":"2019-08-01","paymentDate":"2019-08-15","value":0.3515625,"currency":"USD"},{"executeDate":"2019-10-31","recordDate":"2019-11-01","paymentDate":"2019-11-15","value":0.3515625,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1176,"buy":0,"hold":0.8235,"sell":0.0588,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8235,"analysts":17,"updateTime":1769835600000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRS\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2603665390","title":"Enhanced Genetype colorectal cancer risk test released - supports earlier disease detection and ColoSTAT® targeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2603665390","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603665390?lang=en_us&edition=fundamental","pubTime":"2026-01-14 11:40","pubTimestamp":1768362000,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ --Rhythm Biosciences Ltd  , a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneTypeTM Colorectal Cancer  Risk Assessment clinical test , a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score , delivering improved predictive accuracy across both genders and a wider age range.The enhanced test is designed to support earlier identification of individuals at elevated risk of colorectal cancer, enabling more targeted screening pathways and complementing Rhythm's ColoSTAT blood-based CRC detection test.Validation data for the updated model has been recently published in the peer-reviewed journal PLOS ONE , demonstrating improved predictive performance compared to traditional approaches.Rhythm Biosciences Ltd  is an Australi","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2861328/Rhythm_Biosciences_Vert_CMYK_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/enhanced-genetype-colorectal-cancer-risk-test-released--supports-earlier-disease-detection-and-colostat-targeting-302660578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","PRS","BK4213","LU0456854461.SGD","RHY.AU","LU0266512127.USD","CRC"],"gpt_icon":0},{"id":"2601838806","title":"Press Release: Prudential Financial, Inc. to Announce Fourth Quarter 2025 Earnings; Schedules Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2601838806","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601838806?lang=en_us&edition=fundamental","pubTime":"2026-01-07 21:38","pubTimestamp":1767793080,"startTime":"0","endTime":"0","summary":"Members of Prudential's senior management will host a conference call on Wednesday, February 4, 2026, at 11:00 a.m. ET to review these results.The conference call will be broadcast live on the company's Investor Relations website. Please log on 15 minutes prior to the start of the call in the event necessary software needs to be downloaded.Institutional investors, analysts, and other interested parties are invited to listen to the call by dialing one of the following numbers:. The call will be made available from 3:00 p.m. ET on February 4 through February 18 via the following numbers:. A replay will also be available on the company's Investor Relations website through February 18. Questions may be directed to Investor Relations at investor.relations@prudential.com.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRS","PFH"],"gpt_icon":0},{"id":"2588833629","title":"Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2588833629","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588833629?lang=en_us&edition=fundamental","pubTime":"2025-12-04 23:14","pubTimestamp":1764861240,"startTime":"0","endTime":"0","summary":"GENinCode partners with Thermo Fisher to scale its genetic heart risk test across the US and EMEA as it advances FDA review and expands commercial access.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/04/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/04/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/m-a/25/12/49210289/thermo-fisher-teams-up-with-uk-firm-to-scale-genetic-heart-disease-screening","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/25/12/49210289/thermo-fisher-teams-up-with-uk-firm-to-scale-genetic-heart-disease-screening","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["GB00BDT5M118.USD","LU1720051108.HKD","LU2125909759.SGD","LU1057294990.SGD","LU1153585028.USD","LU1280957306.USD","LU0949170772.SGD","LU0011850046.USD","LU1670628061.USD","LU0316494557.USD","LU0882574055.USD","LU2125909593.SGD","TMO","LU1983299246.USD","LU1548497426.USD","IE0034235188.USD","LU0122379950.USD","LU2720916845.USD","LU1923622291.USD","BK4581","LU2112291526.USD","LU2764262908.HKD","BK4534","IE0009355771.USD","BK4533","LU1791710582.SGD","BK4566","LU1064131342.USD","LU2125910179.SGD","LU2764263203.CNY","IE00BJJMRZ35.SGD","CMS","LU2125909916.SGD","LU1061106388.HKD","IE00B2B36J28.USD","PRS","LU1633808545.USD","LU0823416689.USD","LU2063271972.USD","LU2092937221.SGD","LU1894683348.USD","LU0234572021.USD","LU0545039389.USD","IE0002141913.USD","LU0320765489.SGD","LU1003077747.HKD","LU0345770993.USD","LU2298321311.HKD","LU1988902786.USD","LU2764263039.SGD"],"gpt_icon":0},{"id":"2586225396","title":"PRS REIT Shareholders Approve Strategic Sale and Liquidation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2586225396","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586225396?lang=en_us&edition=fundamental","pubTime":"2025-11-27 21:52","pubTimestamp":1764251539,"startTime":"0","endTime":"0","summary":"PRS REIT Plc ( ($GB:PRSR) ) has issued an announcement. The PRS REIT plc announced that its shareholders have approved the sale of The PRS REIT Hol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prs-reit-shareholders-approve-strategic-sale-and-liquidation-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prs-reit-shareholders-approve-strategic-sale-and-liquidation-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REIT","PRS"],"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PRS\",params:#limit:6,delay:false,,,undefined,":[]}}